Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price on current trading day, fall -19.78% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $16.47.
A look at the stock’s price movement, the close in the last trading session was $20.53, moving within a range at $16.1 and $19.7999. The beta value (5-Year monthly) was 2.238. Turning to its 52-week performance, $1193.28 and $6.76 were the 52-week high and 52-week low respectively. Overall, TNXP moved 50.41% over the past month.
Tonix Pharmaceuticals Holding Corp’s market cap currently stands at around $92.07 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Analysts have a consensus estimate of 4.2M for the company’s revenue for the quarter, with a low and high estimate of 4.2M and 4.2M respectively. The average forecast suggests up to a 69.22% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 17.25M, representing a 70.89% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TNXP is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend TNXP as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TNXP’s current price about 39.37% and -14.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 53.30, while 7-day volatility ratio is 19.79% and 18.98% in the 30-day chart. Further, Tonix Pharmaceuticals Holding Corp (TNXP) has a beta value of 1.35, and an average true range (ATR) of 3.24.
If we refocus on Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), historical trading data shows that trading volumes averaged 2.82 over the past 10 days and 1.62 million over the past 3 months. The company’s latest data on shares outstanding shows there are 155.63 million shares.
The 0.00% of Tonix Pharmaceuticals Holding Corp’s shares are in the hands of company insiders while institutional holders own 2.86% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.55 million on 2025-02-28, giving us a short ratio of 0.36. The data shows that as of 2025-02-28 short interest in Tonix Pharmaceuticals Holding Corp (TNXP) stood at 986.0 of shares outstanding, with shares short rising to 97309.0 registered in 2025-01-31. Current price change has pushed the stock -50.06% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TNXP stock continues to rise going into the next quarter.
